000 | 01992 a2200505 4500 | ||
---|---|---|---|
005 | 20250516081118.0 | ||
264 | 0 | _c20120629 | |
008 | 201206s 0 0 eng d | ||
022 | _a1932-6203 | ||
024 | 7 |
_a10.1371/journal.pone.0032191 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPiecewicz, Stephanie M | |
245 | 0 | 0 |
_aInsulin-like growth factors promote vasculogenesis in embryonic stem cells. _h[electronic resource] |
260 |
_bPloS one _c2012 |
||
300 |
_ae32191 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCarrier Proteins _xmetabolism |
650 | 0 | 4 |
_aCell Differentiation _xdrug effects |
650 | 0 | 4 |
_aEmbryoid Bodies _xcytology |
650 | 0 | 4 |
_aEmbryonic Stem Cells _xcytology |
650 | 0 | 4 |
_aEndothelium _xcytology |
650 | 0 | 4 |
_aExtracellular Signal-Regulated MAP Kinases _xmetabolism |
650 | 0 | 4 |
_aHypoxia-Inducible Factor 1, alpha Subunit _xmetabolism |
650 | 0 | 4 |
_aInsulin-Like Growth Factor I _xpharmacology |
650 | 0 | 4 |
_aInsulin-Like Growth Factor II _xpharmacology |
650 | 0 | 4 |
_aMesoderm _xcytology |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aModels, Biological |
650 | 0 | 4 |
_aNeovascularization, Physiologic _xdrug effects |
650 | 0 | 4 |
_aPodophyllotoxin _xanalogs & derivatives |
650 | 0 | 4 |
_aProtein Stability _xdrug effects |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-akt _xmetabolism |
650 | 0 | 4 |
_aReceptor, IGF Type 1 _xantagonists & inhibitors |
650 | 0 | 4 |
_aReceptor, IGF Type 2 _xantagonists & inhibitors |
650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
650 | 0 | 4 |
_aVascular Endothelial Growth Factor A _xmetabolism |
700 | 1 | _aPandey, Ambarish | |
700 | 1 | _aRoy, Bhaskar | |
700 | 1 | _aXiang, Soh Hua | |
700 | 1 | _aZetter, Bruce R | |
700 | 1 | _aSengupta, Shiladitya | |
773 | 0 |
_tPloS one _gvol. 7 _gno. 2 _gp. e32191 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1371/journal.pone.0032191 _zAvailable from publisher's website |
999 |
_c21572893 _d21572893 |